RPL41 inhibits the lysosomal trafficking of the ARL5B/SKIP/Kinesin-1 signaling pathway by promoting the degradation of ATF4, thereby suppressing the growth and metastasis of retinoblastoma. Here, ATF4 is linked to retinoblastoma.